These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 8765474)

  • 41. Platelet endoperoxide/thromboxane A2 (PGH2/TXA2) receptors in patients with myeloproliferative disorders.
    Faul C; Renn W; Jaschonek K
    Prostaglandins Leukot Essent Fatty Acids; 1991 Aug; 43(4):273-6. PubMed ID: 1835097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization by photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor: evidence for N-linked glycosylation.
    Mais DE; True TA; Martinelli MJ
    Eur J Pharmacol; 1992 Nov; 227(3):267-74. PubMed ID: 1473552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
    Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV
    Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
    Schrör K; Davis-Bruno K; Halushka PV
    Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
    Vezza R; Mezzasoma AM; Venditti G; Gresele P
    Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate.
    Schrör K; Davis-Bruno K; Halushka PV
    Adv Exp Med Biol; 1997; 400A():235-40. PubMed ID: 9547563
    [No Abstract]   [Full Text] [Related]  

  • 47. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets.
    Saussy DL; Mais DE; Baron DA; Pepkowitz SH; Halushka PV
    Biochem Pharmacol; 1988 Feb; 37(4):647-54. PubMed ID: 2963640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
    Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
    Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
    Zehender H; Witte EC; Wolff HP; Patscheke H
    Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].
    Kakushi H; Shike T; Uchida K
    Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-peptide antibodies against the human blood platelet thromboxane A2/prostaglandin H2 receptor. Production, purification and characterization.
    Borg C; Lam SC; Dieter JP; Lim CT; Komiotis D; Venton DL; Le Breton GC
    Biochem Pharmacol; 1993 May; 45(10):2071-8. PubMed ID: 7685602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.
    Saussy DL; Mais DE; Knapp DR; Halushka PV
    Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification of the human blood platelet thromboxane A2/prostaglandin H2 receptor protein.
    Kim SO; Lim CT; Lam SC; Hall SE; Komiotis D; Venton DL; Le Breton GC
    Biochem Pharmacol; 1992 Jan; 43(2):313-22. PubMed ID: 1739420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP; Dorn GW; Rapoport RM
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells.
    Hanasaki K; Nakano K; Kasai H; Arita H
    Biochem Pharmacol; 1989 Sep; 38(18):2967-76. PubMed ID: 2528958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
    Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
    J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.